ArticleOncology letters2015
Analysis of clinical features and prognosis of malignant triton tumor: A report of two cases and literature review.
Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 37 citations in OpenAlex.
- Difficulties in the diagnosis and treatment of axillary malignant triton tumors: A case report.Oncology letters · 2025Article
- Recurrent sporadic malignant triton tumor in the carotid sheath in the absence of neurofibromatosis.The neuroradiology journal · 2024Article
- Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.World journal of surgical oncology · 2023Review
- Clinical diagnostic and radiographic features of recurrent intracranial malignant triton tumor in an adult: illustrative case.Journal of neurosurgery. Case lessons · 2023Article
- Computed tomography imaging features of malignant 'triton' tumor to facilitate its clinical diagnosis: report of two cases.BMC medical imaging · 2022Article
- Liver metastasis 13 years after the resection of a malignant triton tumor originating in the duodenum.International cancer conference journal · 2022Article
- Giant malignant Triton tumour of the posterior mediastinum.Interactive cardiovascular and thoracic surgery · 2021Article
- Malignant triton tumor of the anterior mediastinum: a rare tumor in a rare location.Radiology case reports · 2021Article
- Malignant triton tumour (MTT) of the lung with metastasis to the proximal femur.BMJ case reports · 2021Article
- The importance of surgical margins in malignant Triton tumour of the trunk and extremities.Oncology letters · 2021Article
- Malignant Glandular Triton Tumor Arising in the Radial Nerve with Prolonged Survival: A Case Report and Review of the Literature.Case reports in pathology · 2021Article
- Recurrent epithelioid malignant peripheral nerve sheath tumor with neurofibromatosis type 1: A case report and literature review.Oncology letters · 2019Article
- Malignant Triton Tumor in a Child: Case Report and Literature Review.Cancer management and research · 2019Article
- Malignant triton tumor of the duodenum: report of a case.International cancer conference journal · 2018Article
- Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant triton tumor (MTT) is a malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation. The prognosis of patients is poor, and due to its rarity, large case studies are lacking. The aim of this study is to describe the clinical features and identify potential prognostic factors. Two patients with MTT in the head and neck treated at our department are reported. A literature search revealed another 198 published cases. All of these cases then went through a retrospective analysis. The ratio of male-to-female incidence was 1.5:1, and the median age at diagnosis was 29 years. In 41.7% of cases it occurred in patients with neurofibromatosis type 1. The five-year survival of MTT was found to be just 35%. Cox proportional hazards analysis revealed that complete resection (hazard ratio, 0.396; P=0.032) and metastases (hazard ratio, 3.188; P=0.004) were associated with mortality, indicating that complete resection may lead to a longer life span, and that the existence of metastasis suggested a worse prognosis for patients with MTT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.